Calif. Senate Committee to Hold Hearing on 340B Anti-Discrimination Bill Tomorrow

California state capitol
A bill in the California Senate would bar PBMs from employing practices that 340B covered entities view as discriminatory.

A California Senate health committee has scheduled a hearing for tomorrow on a bill to prohibit pharmacy benefit managers from employing practices that 340B covered entities view as discriminatory.

SB-786 would prohibit PBMs from imposing conditions and exclusions that

Read More »

HHS OIG and HRSA Are Mum About 340B Manufacturer Civil Monetary Penalties and Violation Notices

screenshot of HRSA correspondence to stakeholders web page
HRSA and OIG have no comment on the status of drug manufacturer civil monetary penalties and violation letters stemming from denials of 340B pricing to covered entities that use contract pharmacies.

The U.S. Department of Health and Human Services Office of Inspector General said yesterday it has no comment on the status of referrals from the U.S. Health Resources and Services Administration to fine eight drug manufacturers for failing to offer

Read More »

Calif. Contract Pharmacy Overbilled Medicaid for 340B Drugs, State Appeals Court Holds

PharmBlue specialty pharmacy wordmark
A California state appeals court affirmed a lower ruling that 340B contract pharmacy PharmBlue overbilled the state for 340B drugs it obtained from manufacturers on its clients' behalf.

A California state appeals court has affirmed a lower state court’s judgement that a 340B contract pharmacy overcharged the state Medicaid agency, Medi-Cal, nearly $2.5 million more than the pharmacy was entitled to receive for 340B drugs between May 2015

Read More »

Arkansas and 340B Providers Ask Appeals Court to Back State’s Novel 340B Contract Pharmacy Law

Arkansas Act 1103 text excerpt.
The state of Arkansas and Arkansas 340B covered entities asked a federal appeals court yesterday to uphold the state's novel 340B anti-discrimination law.

The state of Arkansas and Arkansas 340B covered entities separately asked a federal appeals court yesterday to back a judge’s decision in December that the state’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the

Read More »

AHA Again Blasts PhRMA and NACHC’s Alliance to Remake 340B

screenshot of the AHA blog
The AHA slammed PhRMA and NACHC's 340B reform alliance again, this time in its blog and related talking points.

The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.”

Read More »

Senate HELP Panel Likely Leaving 340B Out of Bipartisan Drug Policy Bill That it’s Fast-Tracking

Senate HELP hearing room sign on wall
U.S. Senate HELP staff members reportedly are assembling bipartisan drug policy legislation for a vote maybe as soon as next week, but 340B is expected to be left out of the equation.

U.S. Senate Health, Education, Labor, and Pensions Committee staff members reportedly have decided to exclude 340B issues from a bipartisan drug policy bill they are writing behind the scenes in order to preserve the bill’s odds of being passed next

Read More »

News Alert

Spanberger and Johnson Reintroduce PROTECT 340B Act in Congress

Rep. Dusty Johnson (R-SD) and Rep. Abigail Spanberger (D-VA) headshots
U.S. Reps. Dusty Johnson (R-S.D.) and Abigail Spanberger (D-Va.) reintroduced legislation to protect 340B covered entities, contract pharmacies, and individuals with private insurance from discrimination by pharmacy benefit managers and insurance companies.

A Virginia Democrat and South Dakota Republican this afternoon reintroduced bipartisan legislation in the U.S. House to protect 340B covered entities and contract pharmacies from discrimination by insurers and pharmacy benefit managers.

Reps. Abigail Spanberger (D-Va.) and Dusty Johnson (R-S.D.)

Read More »

Novartis to Appeals Court: Our New 340B Contract Pharmacy Policy Doesn’t Affect Our Case Before You

Novartis wordmark on a building
Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.

Drug maker Novartis told a federal appeals court in Washington, D.C. Tuesday its revised 340B contract pharmacy policy “does not impact the legal arguments at issue” in its 340B contract pharmacy case awaiting the court’s decision.

If the court disagrees,

Read More »

Two GOP Senators Raise Concerns About PBM’s Infringement on 340B Savings in Recent Hearing

Jonathan Levitt pictured at Senate hearing
The 340B program "is completely frustrated" by pharmacy benefit managers, health care attorney Jonathan Levitt said during a during a Senate Finance Committee hearing on PBMs.

Two Republican U.S. senators expressed concerns about pharmacy benefit manager encroachment on 340B covered entity savings during a Senate Finance Committee hearing on PBMs last week.

“I often hear concerns from South Dakota hospitals and health centers when it comes

Read More »

Hospitals Shouldn’t Fear 340B Reporting Requirements, House E&C Republicans Say; Democrat Matsui Raises Concern About Scapegoating

Rep. Larry Bucshon (R-IN) pictured at house hearing
“I don't think there's any anything hospitals should be afraid of when it comes to 340B transparency," Rep. Larry Bucshon (R-Ind.) said during a hearing last week.

Requiring hospitals to report what they make from 340B drug discounts versus what they spend on charity care could be a first step toward tackling full-scale 340B program reform later, a senior Republican on the U.S. House committee with jurisdiction

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live